9 days ago
RZLT
AnalystsJulian HarrisonJulian Harrison's Stock Forecasts
AnalystsJulian Harrison
Sectors:
Industries:
Analyst Ranking
Top 3%
#133 out of 5294 analysts
Average Return
+32.88%
Win Rate
56%80 out of 143
Risk vs Reward
Poor
Good
Julian Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Climb Bio IncCLYM | +453.85% | $1.95 | $10.80 | 2025-10-16 - 2026-06-10 | Strong Buy |
Climb Bio IncCLYM | +437.31% | $2.01 | $10.80 | 2025-09-30 - 2026-06-10 | Strong Buy |
Spyre Therapeutics IncSYRE | +406.61% | $14.82 | $75.08 | 2025-09-16 - 2026-06-10 | Strong Buy |
Climb Bio IncCLYM | +365.52% | $2.32 | $10.80 | 2025-09-22 - 2026-06-10 | Strong Buy |
Oruka Therapeutics IncORKA | +295.00% | $16.21 | $64.03 | 2025-09-17 - 2026-06-10 | Strong Buy |
Julian Harrison Analyst Color
Get additional color on Julian Harrison's coverage of popular stocks
a month ago
INVA
a month ago
CLYM
a month ago
AVTX
a month ago
ORKA
2 months ago
SYRE
2 months ago
ORKA
3 months ago
JBIO
4 months ago
NKTR
5 months ago
ARDX
5 months ago
ABVX
5 months ago
APGE
5 months ago
APGE
7 months ago
TBPH
7 months ago
CGEM
7 months ago
RNAC
7 months ago
ORKA
8 months ago
ABVX
8 months ago
CLYM
9 months ago
MAZE
a year ago
TBPH
2 years ago
OTLK
2 years ago
VRDN
2 years ago
VRDN
2 years ago
PTGX
Julian Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cartesian Therapeutics IncRNAC | 3 | Strong Buy | $44.00 | +492.19% | Reiterates | 2 days ago |
Moonlake ImmunotherapeuticsMLTX | 7 | Strong Buy | $30.00 | +71.53% | Reiterates | 2 days ago |
Climb Bio IncCLYM | 6 | Strong Buy | $19.00 | +75.93% | Reiterates | 3 days ago |
Abivax SaABVX | 6 | Strong Buy | $150.00 | +53.01% | Reiterates | 9 days ago |
Rezolute IncRZLT | 6 | Strong Buy | $6.00 | +57.48% | Maintains | 9 days ago |
Jade Biosciences IncJBIO | 7 | Strong Buy | $74.00 | +384.93% | Maintains | 10 days ago |
Apogee Therapeutics IncAPGE | 7 | Strong Buy | $137.00 | +65.62% | Reiterates | 15 days ago |
Innoviva IncINVA | 4 | Strong Buy | $42.00 | +82.61% | Reiterates | 16 days ago |
Cullinan Therapeutics IncCGEM | 5 | Strong Buy | $38.00 | +215.35% | Reiterates | 23 days ago |
Oruka Therapeutics IncORKA | 8 | Strong Buy | $151.00 | +135.83% | Reiterates | a month ago |
Mereo Biopharma Group PLCMREO | 4 | Strong Buy | $1.00 | +227.87% | Reiterates | a month ago |
Liquidia CorpLQDA | 8 | Strong Buy | $59.00 | -9.58% | Maintains | a month ago |
Avalo Therapeutics IncAVTX | 5 | Strong Buy | $58.00 | +342.75% | Maintains | a month ago |
Nektar TherapeuticsNKTR | 5 | Strong Buy | $178.00 | +213.49% | Maintains | 2 months ago |
Spyre Therapeutics IncSYRE | 8 | Strong Buy | $98.00 | +30.53% | Maintains | 2 months ago |
Akebia Therapeutics IncAKBA | 5 | Strong Buy | $4.00 | +358.19% | Reiterates | 2 months ago |
Connect Biopharma Holdings LtdCNTB | 4 | Strong Buy | $10.00 | +380.77% | Reiterates | 2 months ago |
Tvardi Therapeutics IncTVRD | 2 | Strong Buy | $15.00 | +455.56% | Reiterates | 2 months ago |
Maze Therapeutics IncMAZE | 6 | Strong Buy | $46.00 | +94.42% | Reiterates | 3 months ago |
Theravance Biopharma IncTBPH | 6 | Strong Buy | $21.00 | +28.28% | Reiterates | 3 months ago |
Ardelyx IncARDX | 3 | Strong Buy | $17.00 | +203.03% | Reiterates | 4 months ago |
Viridian Therapeutics IncVRDN | 4 | Strong Buy | $61.00 | +286.81% | Reiterates | 7 months ago |
Protagonist Therapeutics IncPTGX | 3 | Strong Buy | $82.00 | -22.47% | Reiterates | 7 months ago |
Outlook Therapeutics IncOTLK | 4 | Strong Buy | $9.00 | N/A | Maintains | 2 years ago |
Aclaris Therapeutics IncACRS | 3 | Strong Buy | $8.00 | N/A | Upgrades | 2 years ago |
Vyne Therapeutics IncVYNE | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Reinstates | 3 years ago |
Cymabay Therapeutics IncCBAY | 7 | Strong Buy | $24.00 | N/A | Maintains | 3 years ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $105.00 | N/A | Maintains | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Strong Buy | $181.00 | N/A | Maintains | 4 years ago |
Biora Therapeutics IncBIOR | 1 | Strong Buy | $4.00 | N/A | Assumes | 4 years ago |
United Therapeutics CorpUTHR | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $64.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.